The new formulation targets internal and external parasites, expanding the BRAVECTO® portfolio Rahway, NJ, – November 26, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for BRAVECTO® TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets […]
Romain Delcombel, Joao Lopes and Jaap de Wit were recognized for their work to advance swine innovation and technology Rahway, NJ, November 13, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the winners of the 2024 High-Quality Pork Pignnovation Award. Following a competitive review process, Romain […]
Vaccine can now be administered intramuscularly or through subcutaneous injection as well as at the same time as BOVILIS® CRYPTIUM® Subcutaneous injections are generally well-tolerated by animals, can minimize pain and distress, and improve meat quality[i] Rahway, N.J., October 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA […]
RAHWAY, N.J., August 29, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than six million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Many communities where rabies outbreaks persist, have limited access to resources and vaccines,” said Ingrid Deuzeman, […]
New vaccine protects against two of the most common swine diseases, while offering animal-friendly and efficient administration through IDAL® device technology Rahway, NJ, Sept. 25, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency has granted the marketing authorization in the […]
Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly USDA-approved NOBIVAC® NXT vaccine platform to include a best in class solution […]
Launch coincides with new updates to SenseHub Ecosystem and SenseHub Dairy aimed at increasing capabilities and efficiencies for herds of all size Rahway, NJ. August 09, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the availability of SenseHub™ Dairy Youngstock for preweaned calves in individual […]
Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits RAHWAY, N.J., July 9, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN).. The completion of this acquisition […]
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease RAHWAY, N.J., June 25, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the USDA approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of […]
First-of-its-kind line of vaccines leverages state-of-the-art RNA-particle technology to protect cats and dogs from rabies RAHWAY, N.J., June 17, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the launch and availability of the NOBIVAC® NXT Rabies portfolio – consisting of NOBIVAC® NXT Feline-3 Rabies and […]